Sorry Dems, Comey's words too weak to impeach Trump

New Post Public Reply Private Reply Replies (1) Message Board
john1234 HOT #37087
180
Sorry Dems, Comey's words too weak to impeach Trump


Jonathan Turley, opinion contributor 2 hrs ago

Editor’s note: The opinions in this article are the author’s, as published by our content partner, and do not necessarily represent the views of MSN or Microsoft.


If revenge is a dish best served cold, former FBI director James Comey's testimony was a true Beltway feast. Comey delivered the most dispassionate and devastating delivery possible in portraying President Trump as the new Richard Nixon - just a lot less likeable. Despite the effort of GOP members to undermine Comey's credibility, he retained his signature Eagle Scout image in expressing his unease with a series of alleged and grossly inappropriate comments from the president.

The testimony unleashed a torrent of Watergate analogies, and even Watergate-era figures like Carl Bernstein and John Dean were called forth to complete the analogy. Yet, if anything, the testimony showed how fanciful these analogies have become.

First and foremost, I am perfectly willing to accept Comey's account in this hearing. However, even accepting those representations as true, they did not describe a crime or an impeachable offense. Comey confirmed that Trump actually agreed that it would be a good idea for the Russian investigation to go forward and not be terminated artificially.

Comey also confirmed that Trump only expressed a "hope" that the Flynn investigation would end - a statement that Trump made repeatedly publicly. He also confirmed that Trump was primarily asking him to make public what he had already told Congress - that he was not under personal investigation.


Obviously, Trump does not come over well in this account (an account that he had denied). Comey testified that he immediately began the practice of writing down notes from meetings with Trump after the election because of "the nature of the person. I was honestly concerned that he might lie about the nature of our meeting." Again, however, having a duplicitous or dishonest nature is not an impeachable offense. Indeed, if that standard were applied in Washington generally, it would be a ghost town.

The saturation of Watergate analogies in the media, however, seems wildly detached from either the actual testimony or history. If Watergate was a cancer growing on the presidency, this is still little more than a canker sore - not great to look at but hardly life threatening. It could get worse but what Comey described in his testimony was boorish and even brutish but not necessarily an indictable or impeachable offense. Article I is not a book of etiquette for presidents. If Trump said these things to Comey, they are incredibly improper and ill-advised. Yet, the Nixon comparison works in favor of the position of Trump more than it does Comey.

Comey recounted his discomfort over allegedly being told that Trump wanted assurances of his loyalty and repeatedly asked him to scuttle the investigation of former National Security Advisor Michael Flynn. However, Comey confirmed that he did in fact assure Trump that the president was not under investigation not once but three times. That is significant on two levels. First, if it was grossly inappropriate for Trump to ask the question (and it was), it was equally inappropriate for Comey to answer it (three times). Second, whatever Trump asked of Comey was done in the knowledge that he himself was not viewed as a target for investigation.

Comey also confirmed that Trump asked for him to end the investigation of Flynn, not the Russian investigation as a whole. Flynn had just been fired the day before and Trump could argue that he was expressing sympathy for an aide who had been put through a great deal and was still only accused of relatively minor criminal conduct like violating the Foreign Agents Registration Act.

I tend to view these things through the lens of a criminal defense counsel and there are a myriad of possible interpretations other than obstruction. The same can be said of the loyalty discussion. Trump's young administration was being ripped apart by leaks from national security and law enforcement sources. Comey was widely viewed with suspicion by many in the administration. The comment could be viewed in that context rather than some grand Watergate-esque conspiracy.

That brings us back to Watergate. On CNN, Jeffrey Toobin pointed to John Dean sitting next to him to reaffirm that this was now a strong case of obstruction. Toobin stated that Dean (who agreed that the evidence supports a charge of obstruction) knew what he was talking about because he went to jail for obstruction during Watergate. However, the Dean comparison only highlights the overhyped analogy. Dean pled guilty to giving hush money to the Watergate burglars to keep them quiet. That is obstruction. Telling an FBI director that a recently resigned aide is a good guy (something Comey agreed with) and he hoped that he could be now left alone is hardly analogous.

A comparison to the first article of impeachment for Nixon is equally illustrative. The much-touted article accused Nixon of not expressing his desire for the termination of one (but not all investigations) or the suggestion that he might not retain a director for a lack of loyalty. It details extensive criminal conduct on the part of Nixon "to delay, impede, and obstruct the investigation of such illegal entry; to cover up, conceal and protect those responsible; and to conceal the existence and scope of other unlawful covert activities."

What followed that statement was a list of nine specific allegations including false and misleading statement to investigators, withholding evidence, procuring false testimony of others, interfering with federal and congressional proceedings, the payment of hush money to witnesses and targets, misuse of the CIA to obstruct the investigation, passing along investigative information to criminal suspects to assist their efforts to evade prosecution, making false information to the public to conceal criminal conduct, and rewarding possible witnesses for their silence of false testimony. Virtually all of those listed items are crimes in their own right.

Of course, one of the most striking differences is that James Comey is no John Dean. Dean went to Nixon to confront him on the cancer growing on the presidency. Comey said nothing to Trump about his misgivings in meeting alone or his comments. He wrote a memo to file. While he did (to his credit) raise the issue with his staff, Comey admits that he did not raise the impropriety of Trump's questions or conduct with the president.

Comey's testimony is more illustrative of his view of the nature of Donald Trump than the nature of any alleged crime. A criminal defense counsel would have a field day on these facts if a charge was ever brought. Every factual assertion can be either menacing or mundane, depending on your assumptions about Trump and his motivations. In comparison to the first article of impeachment of Nixon, it is the difference between high crimes and high anxiety.

Jonathan Turley is the Shapiro Professor of Public Interest Law at George Washington University. He served as the lead defense counsel on behalf of Judge Thomas Porteous in the last impeachment trial in the United States Senate.

source
http://www.msn.com/en-us/news/opinion/sorry-d...li=BBnb7Kz
Scroll down for more posts ▼

Top 10 Most Recent News Articles

JiMMYBAR! Expands Creatine Market with Target Launch

Updated Category News Views 25

JiMMYBAR! Breaks New Ground in Supplements You ever notice how some companies just know how to shake things up? Take JiMMYBAR!, for instance. The moment I read they’re making moves to get their Creatine + Protein bars into Target stores nationwide, starting October 4, I thought, “That’s one way to drag creatine out from the dusty tub and onto the shelves of...

Continue Reading
Purina Institute Highlights Nutritional Science at WSAVA 2026

Updated Category News Views 19

A Global Stage for Pet Nutrition Science The folks over at the Purina Institute are back in the spotlight as they gear up to throw their weight behind the 51st World Small Animal Veterinary Association (WSAVA) Congress in Warsaw, Poland. Set for October 13-15, 2026, this isn’t just another event—they're bringing some serious clout with their 'Food for Thought'...

Continue Reading
Cure Blindness Project's 770K Screenings for World Sight Day

Updated Category News Views 22

Visionary Steps Toward a Brighter Future No two words could describe the task that Cure Blindness Project is tackling this year: vision and action. Marking World Sight Day on October 8, they plan to usher in 770,000 eye screenings across Asia, Africa, and the Caribbean. These initiatives aren't just numbers—they're a colossal step toward lifting the veil of avoidable...

Continue Reading
NYSE Texas Redefines the U.S. Capital Markets Landscape

Updated Category News Views 19

NYSE Texas: Carving a Niche The notion of 'Y'all Street' might seem like a gimmick, but NYSE Texas is pushing a serious agenda with its newly released white paper, 'NYSE Texas and the Reshaping of U.S. Capital Markets.' This is no small feat. Texas is already housing 235 NYSE-listed companies, boasting a colossal combined worth of $4.8 trillion. With 130 of these firms...

Continue Reading
Navigating Holiday Sweets: Healthy Balancing Acts

Updated Category News Views 21

In the middle of the sweet madness that is the holiday season, Crispy Green and Dr. Nicole Avena are playing guide to families drowning in sugar. This isn't just a once-a-year Halloween headache; we're starting that sugar spiral early and letting it ride until the New Year approaches. It's an all-hands-on-deck situation if families want to dodge that sugar overload. Why...

Continue Reading
Charter Next Generation Unveils Gen 2 MDO-PE Films

Updated Category News Views 14

Peering Into CNG's Latest Innovation Charter Next Generation (CNG) just threw down a hefty gauntlet with its launch of next-gen machine-direction-oriented polyethylene (MDO-PE) solutions. They're pushing the envelope on what recycle-ready packaging can do, folks. Let's not mince words—other players in the field better have their game faces on. This ain't just another...

Continue Reading
Cala Launches Game-Changer Wearable for Tremor Relief

Updated Category News Views 12

Breaking New Ground in Neuromodulation Medical tech's on a roll, and Cala Health just hopped on the fast track with their latest launch—the Cala kIQ Plus System. This bad boy is aiming to offer relief for those grappling with hand tremors, thanks to its FDA clearance and a host of new features. It's the first of its kind, combining multiple therapy modes with an...

Continue Reading
Northern Jet Names Veteran Matthew Harris as CEO

Updated Category News Views 28

Fresh Leadership at Northern Jet Well, if you didn’t see this coming, you’ve been snoozing on the tarmac. Northern Jet, no stranger to the skies after three decades, just roped in Matthew Harris as their new CEO from October 2, 2026. They're pulling in this hotshot with more than 25 years riding the turbulence of private aviation. And listen to this: his marching...

Continue Reading
Skandia's Soundproofing Kit Expands to Brazil's Skies

Updated Category News Views 14

Soundproofing Takes Off in Brazil Skandia has just pulled off a neat trick, earning the nod from Brazil's National Civil Aviation Agency (ANAC) for their King Air soundproofing kit. That means quieter skies ahead for operators of the King Air 200 and 300 series in Brazil. This is no small feat, folks; it's like finally getting that coveted backstage pass after years of...

Continue Reading
Karoo Health Leaps Forward with New CCO Breton

Updated Category News Views 16

Change of Guard in Cardiac Health at Karoo Here's a move that might shake things up in the healthtech sector: Karoo Health just snagged Angela "Angie" Breton as their new Chief Commercial Officer. It's like putting a seasoned captain at the helm right before setting sail on uncharted waters. Breton's not just any captain—she's got a hefty 25 years of experience...

Continue Reading

Top 5 Most Recently Viewed Articles

Health-E Commerce® Showcases Innovative Spending Account Tools

Updated Category News Views 106

Health-E Commerce® to Highlight FSA and HSA Tools at Symposium Health-E Commerce®, the parent brand of FSA Store® and HSA Store®, is preparing to showcase its innovative e-commerce integrations and participant education resources at the 38th Annual ECFC Symposium. This event promises to be an excellent opportunity for third-party administrators (TPAs) and employers...

Continue Reading
Best Free Machinery Appraisal and Valuation Services

Updated Category Business Views 24

Businesses often need to know what idle or surplus machinery is worth before deciding what to do with it. A market valuation can help you compare resale, redeployment, liquidation, and other asset disposition options. Professional machinery appraisal services often involve a fee. However, some industrial equipment companies provide free market valuations based on...

Continue Reading
Super Hi's Impressive Q1 Financial Growth and Future Plans

Updated Category News Views 232

Super Hi's Strong Financial Performance in Q1 2025 Super Hi International Holding Ltd. (NASDAQ: HDL and HKEX: 9658), a cornerstone in the realm of Chinese cuisine known for its Haidilao hot pot restaurants, reported its unaudited financial performance for the first quarter of 2025. As the brand continues to rise in prominence, its results indicate a sustainable growth...

Continue Reading
ELEGOO Makes Strides in 3D Printing at IFA 2025 Showcase

Updated Category News Views 288

ELEGOO's Groundbreaking Presentation at IFA 2025 Shenzhen, China - ELEGOO, known for rapidly advancing in smart manufacturing, is set to make a significant impression at IFA 2025, Europe's premier consumer electronics show taking place from September 1-5. This marks the company's first appearance at this esteemed event. ELEGOO aims to revolutionize how everyday people...

Continue Reading
Gordon Smith Steps Up to Humana Board, Strengthening Leadership

Updated Category News Views 294

Gordon Smith Joins Humana's Board of Directors Humana Inc. (NYSE: HUM), a leading health and well-being company, has announced the election of Gordon Smith to its Board of Directors. Smith serves as an Operating Advisor at Clayton, Dubilier & Rice LLC (CD&R), and brings an extensive background from his time at JPMorgan Chase, where he was Co-President and Co-Chief...

Continue Reading